First phase of Ebola vaccine human trials set to begin
An Ebola vaccine produced by GlaxoSmithKline is being tested on healthy volunteers. In addition to 40 people in Mali, 20 are being tested at the National Institutes of Health in the United States, as well as 60 in the United Kingdom. Dr. Jon LaPook reports.